Microbiology Testing Market Analysis

Microbiology Testing Segmentation

Application (Pharmaceutical, Clinical, Food Testing, Energy, Chemical)

The pharmaceutical segment in the microbiology testing market is set to gain the largest revenue share of about 35% in the year 2035. The segment growth can be attributed to the increasing applications of microbiology testing in drug discovery, quality control and safety testing in the pharmaceutical industry. Moreover, rising R&D spending in the pharma sector is attributed to segment growth. For instance, each year, the pharma industry spends USD 100 billion on R&D.

Product (Instruments, Reagents)

The instruments segment is slated to hold about 57% share of the global microbiology testing market in the year 2035. The growth of the segment is impelled by the growing demand for rapid and automated testing methods, the increasing prevalence of infectious diseases, and the growing awareness about food safety and quality standards. Additionally, the growing demand for cost-effective methods for testing such as PCR, next-generation sequencing (NGS), and microarray-based testing and the increasing number of regulations mandating the testing in food, healthcare and other industries are also driving the instruments segment growth.

Our in-depth analysis of the global market includes the following segments:

Test Type	Bacterial Viral Fungal
Product	Instruments Reagents
Diseases	Respiratory Bloodstream Infections Gastrointestinal Sexually Transmitted Diseases Urinary Tract Infection Periodontal
Application	Pharmaceutical Clinical Food Testing Energy Chemical

Frequently Asked Questions (FAQ)

Increasing prevalence of infectious diseases, the rising demand for rapid and cost-effective tests are the major factors driving the market growth.

The market size of microbiology testing is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023 â€“ 2035.

The major players in the market are Neogen Corporation., STEMart, Masimo, Koninklijke Philips N.V., GE Healthcare, and others.

The pharmaceutical segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The microbiology testing market is estimated to be USD 4 Billion by 2022 and forecasted to be USD 10 Billion by 2035.

This is propelled by the growing demand for rapid and automated testing methods, the increasing prevalence of infectious diseases, and the growing awareness about food safety and quality standards.

The unavailability of skilled personnel, issues with test accuracy and high cost of testing are some of the growth hampering factors affecting microbiology testing market.

Microbiology Testing Market Analysis